| LAML |
Acute Myeloid Leukemia |
| ACC |
Adrenocortical carcinoma |
| BLCA |
Bladder Urothelial Carcinoma |
| LGG |
Brain Lower Grade Glioma |
| BRCA |
Breast invasive carcinoma |
| CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
| CHOL |
Cholangiocarcinoma |
| LCML |
Chronic Myelogenous Leukemia |
| COAD |
Colon adenocarcinoma |
| CNTL |
Controls |
| ESCA |
Esophageal carcinoma |
| FPPP |
FFPE Pilot Phase II |
| GBM |
Glioblastoma multiforme |
| HNSC |
Head and Neck squamous cell carcinoma |
| KICH |
Kidney Chromophobe |
| KIRC |
Kidney renal clear cell carcinoma |
| KIRP |
Kidney renal papillary cell carcinoma |
| LIHC |
Liver hepatocellular carcinoma |
| LUAD |
Lung adenocarcinoma |
| LUSC |
Lung squamous cell carcinoma |
| DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
| MESO |
Mesothelioma |
| MISC |
Miscellaneous |
| OV |
Ovarian serous cystadenocarcinoma |
| PAAD |
Pancreatic adenocarcinoma |
| PCPG |
Pheochromocytoma and Paraganglioma |
| PRAD |
Prostate adenocarcinoma |
| READ |
Rectum adenocarcinoma |
| SARC |
Sarcoma |
| SKCM |
Skin Cutaneous Melanoma |
| STAD |
Stomach adenocarcinoma |
| TGCT |
Testicular Germ Cell Tumors |
| THYM |
Thymoma |
| THCA |
Thyroid carcinoma |
| UCS |
Uterine Carcinosarcoma |
| UCEC |
Uterine Corpus Endometrial Carcinoma |
| UVM |
Uveal Melanoma |